ketotifen has been researched along with Genital Neoplasms, Female in 1 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Genital Neoplasms, Female: Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
The, FO | 1 |
Buist, MR | 1 |
Lei, A | 1 |
Bennink, RJ | 1 |
Hofland, J | 1 |
van den Wijngaard, RM | 1 |
de Jonge, WJ | 1 |
Boeckxstaens, GE | 1 |
1 trial available for ketotifen and Genital Neoplasms, Female
Article | Year |
---|---|
The role of mast cell stabilization in treatment of postoperative ileus: a pilot study.
Topics: Adult; Aged; Double-Blind Method; Female; Gastric Emptying; Gastrointestinal Transit; Genital Neopla | 2009 |